Delisting risk
Purple Biotech (ADR) (PPBT)
Develops CAPTN-3 tri-specific cancer antibodies and other oncology drug candidates.
$1.81
Pre-market−0.17 (−8.35%)
At close$1.98(+18.98%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions14 holders · as of Mar 31, 2026 | 54.79% | 75.7K ADS | |
| Otherremainder | 45.21% | 62.4K ADS |
138.1K ADS as of Aug 21, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
The share count has not been confirmed by a second filing; stakes use it as it stands.
Some positions are filed in underlying shares, not receipts; the ratio is unknown, so no percentage.
A stock split fell inside the quarter, so quarter-on-quarter changes are not shown.
Institutions13F, as of Mar 31, 2026
14 holders · 75.7K shares
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Susquehanna International Group, LLP | 53.4K | 38.67% | May 15, 2026 | |
| Smartharvest Portfolios, LLC | 18.1K | 13.13% | Apr 21, 2026 | |
| BNP Paribas Arbitrage, SNC | 2.0K | 1.42% | May 12, 2026 | |
| Rhumbline Advisers | 710 | 0.51% | May 12, 2026 | |
| Simplex Trading, LLC | 597 | 0.43% | May 14, 2026 | |
| Morgan Stanley | 578 | 0.42% | May 15, 2026 | |
| Gamma Investing LLC | 108 | 0.08% | Apr 6, 2026 | |
| UBS Group AG | 99 | 0.07% | May 5, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Mitchell P. Kopin | 9.99% | 13G | May 13, 2026 ↗ | |
| Lincoln Alternative Strategies LLC | 9.90% | 13G | Sep 9, 2025 ↗ | |
| Susquehanna Securities, LLC | 5.20% | 13G | Feb 13, 2026 ↗ |
Insider tradesForm 4
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.
